Study of Dupilumab in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis
Clinical trial NCT01548404 · COMPLETED
Trial details
- NCT number
- NCT01548404
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-04-01
- Primary completion
- 2013-03-01
- Enrollment
- 109
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.